Mount Sinai Hosp Med School

New York, New York 10029

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-Resistant Prostate Cancer (mCRPC), Prostatic Neoplasms

Studies at this site

• 177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer — Running, not enrolling
• Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function — Running, not enrolling